Original Article
Keratin 8 Mutations in Patients with Cryptogenic Liver Disease
N Engl J Med 2001; 344:1580-1587May 24, 2001
- Abstract
Background
About 10 percent of patients who undergo liver transplantation have cryptogenic liver disease. In animal models, the absence of heteropolymeric keratins 8 and 18 or the presence of mutant keratins in hepatocytes causes or promotes liver disease. We have previously described a mutation in the keratin 18 gene in a patient with cryptogenic cirrhosis, but the importance of mutations in the keratin 8 and keratin 18 genes in such patients is unclear.
Methods
We tested for mutations in the keratin 8 and keratin 18 genes in purified genomic DNA isolated from 150 explanted livers and 89 peripheral-blood specimens from three groups of patients: 55 patients with cryptogenic liver disease; 98 patients with noncryptogenic liver disease, with causes that included alcohol use, autoimmunity, drug use, and viral infections; and 86 randomly selected inpatients and outpatients who provided blood to the hematology laboratory.
Results
Of the 55 patients with cryptogenic liver disease, 3 had glycine-to-cysteine mutations at position 61 (a highly conserved glycine) of keratin 8, and 2 had tyrosine-to-histidine mutations at position 53 of keratin 8. These mutations were not detected in the patients with other liver diseases or in the randomly selected patients. In transfected cells, the glycine-to-cysteine mutation limited keratin-filament reorganization when the cells were exposed to oxidative stress. In contrast, the tyrosine-to-histidine mutation destabilized keratin filaments when transfected cells were exposed to heat or okadaic acid stress.
Conclusions
Mutations in the keratin 8 gene may predispose people to liver disease and may account for cryptogenic liver disease in some patients.
Media in This Article
Figure 1
Identification of Mutations in the Keratin 8 Gene and Expression of Mutant Keratin 8.Figure 2
Immunofluorescence Staining of NIH 3T3 Cells Transfected with Wild-Type and Mutant Keratin 8 Constructs.Article Activity
- Article
Keratins comprise a group of intermediate-filament cytoskeletal proteins with more than 20 members. They are expressed in epithelial cells and are classified as type I (keratins 9 through 20) or type II (keratins 1 through 8).1,2 Epithelial cells express at least one type I keratin and one type II keratin, which form noncovalent heteropolymers in a 1:1 ratio. Keratins 8 and 18 are found primarily in single-layered epithelia (e.g., within the liver, pancreas, and intestine), whereas heteropolymers of keratins 5 and 14 are found in basal keratinocytes of stratified epithelium and heteropolymers of keratins 1 and 10 are found in suprabasal keratinocytes of stratified epithelium.1-4
Of the “soft” keratins (those other than the “hard” keratins of epidermal appendages), there are 13 (keratins 1 through 6 and keratins 9, 10, 12, 13, 14, 16, and 17) in which mutations have been associated with primarily autosomal dominant epidermal, oral, and ocular diseases.3,5-8 Studies in animal models suggest that the liver and intestine are likely targets of disease in the presence of mutations in the genes for keratin 8 and keratin 18.4,9,10 For example, in one strain of mice that lack expression of the keratin 8 gene, most of the mice have extensive liver hemorrhage and die before birth.11 In another strain, some mice have rectal prolapse, colitis, mild elevations in aminotransferase levels,12 hepatocyte fragility,13 and marked susceptibility to hepatotoxin-induced liver injury.13-15 These various phenotypes highlight the importance of other modifier genes in the manifestation of a disease phenotype. Similarly, transgenic mice that overexpress mutant keratin 18 have mild chronic hepatitis, fragile hepatocytes, and marked susceptibility to drug-induced liver injury.14,16,17
These findings led to the hypothesis that mutations in the genes for keratin 18, keratin 8, or both may cause or predispose people to acute or chronic liver disease that would otherwise be classified as cryptogenic.9 We previously described a mutation in the keratin 18 gene (the substitution of leucine for histidine at position 127) in 1 of 28 patients with cryptogenic cirrhosis.18 We report the identification of five additional, unrelated patients who had mutations in the keratin 8 gene that may have predisposed them to cryptogenic cirrhosis.
Methods
Patients
We analyzed specimens of 150 explanted livers, which were obtained from the liver-transplantation units at the University of California–San Francisco and California Pacific Medical Center, and peripheral-blood samples from 1 patient with cryptogenic cirrhosis, 2 patients with neonatal hepatitis, and 86 other randomly selected (control) patients seen at the Palo Alto Veterans Affairs Medical Center or Stanford University Medical Center, according to protocols approved by the human-subjects committees at these institutions. All the patients or their parents gave written informed consent.
In 55 patients cryptogenic cirrhosis was diagnosed according to the following criteria: the absence of serologic markers of hepatitis B and hepatitis C and of mitochondrial, nuclear, and smooth-muscle antigens; the presence of normal iron, ceruloplasmin, and alpha1-antitrypsin levels; and the absence of ingestion of alcohol or other hepatic toxins. Of the 98 patients with noncryptogenic liver disease, 20 had alcohol-related disease, 10 hepatitis C, 27 autoimmune hepatitis, 21 acute fulminant hepatitis, 7 drug-induced disease, 3 neonatal hepatitis, 2 primary biliary cirrhosis, 2 Wilson's disease, 2 alpha1-antitrypsin deficiency, 1 chronic rejection, 1 hepatitis B, 1 hemochromatosis, and 1 veno-occlusive liver disease. Among the 153 patients with cryptogenic or noncryptogenic liver disease were 120 previously described patients.18 In addition, peripheral-blood specimens from a control group consisting of 86 randomly selected inpatients and outpatients, all of whom provided blood to the hematology laboratory on a randomly chosen day, were analyzed for mutations. Specimens from the control group were analyzed only by restriction-enzyme digestion for the presence of two mutations in the keratin 8 gene: the substitution of cysteine for glycine at position 61 (G61C) and the substitution of histidine for tyrosine at position 53 (Y53H).
Molecular Methods
NIH 3T3 cells (which do not express keratins) were transfected with both DNA encoding wild-type human keratin 18 and one of three human keratin 8 constructs: constructs encoding wild type, Y53H, or G61C keratin 8.16,18 Transfection of both keratin 8 and keratin 18 stabilizes the keratins and allows the formation of filaments.19,20 Genomic DNA was prepared with a tissue kit (DNeasy, Qiagen, Chatsworth, Calif.). (The sequences of the primers used in the polymerase chain reaction [PCR] are available as Supplementary Appendix 1
Supplementary Appendix 1. Amino Acid Regions of Keratin 8 and Keratin 18 That Were Analyzed for Mutations. with the full text of this article at http://www.nejm.org.) The products of PCR amplification were analyzed (Mutation Detection Enhancement gels with 5 percent glycerol, FMC BioProducts, Rockland, Me.) and sequenced when necessary (ABI 377 sequencer, Applied Biosystems, Foster City, Calif., and the GeneScan Analysis Program, version 2.0.2, Applied Biosystems). Genomic DNA samples with shift patterns according to gene scanning were used to generate a 521-bp species corresponding to the keratin 8 head domain for subsequent sequencing and NcoI and EcoT22I restriction-enzyme digestion.Biochemical Methods
Tissue specimens from explanted livers were homogenized in phosphate-buffered saline containing 1 percent n-dodecyl-N,N-dimethylglycine (Empigen BB, Calbiochem–Novabiochem, San Diego, Calif.), EDTA (5 mmol per liter), and protease inhibitors. The specimens were centrifuged at 16,000×g for 30 minutes, and the clarified supernatant was used for precipitation.18 Immunoprecipitates of the keratin 8–keratin 18 complex were obtained from the explanted livers with the use of anti–K8-K18 antibody L2A116 and then analyzed by one of the following methods: denaturing polyacrylamide-gel electrophoresis under reducing or nonreducing conditions (i.e., with or without mercaptoethanol) followed by staining with Coomassie blue; immunoblotting; or two-dimensional gel analysis (isoelectric focusing in the horizontal direction and polyacrylamide-gel electrophoresis in the vertical direction)21 followed by immunoblotting. Extracts were obtained by solubilizing transfected cells with Laemmli22 sample buffer or by disrupting cells by freezing and thawing, centrifuging (to obtain a cytosolic fraction), and then solubilizing the pellet with sample buffer. Antibodies (Neomarkers, Union City, Calif.) that are specific for keratin 8 alone (antibody M20) or keratin 18 alone (antibody DC10) were used for immunoblotting.
Immunofluorescence Staining
NIH 3T3 cells transfected with DNA encoding both keratin 8 and keratin 18 were fixed in 100 percent methanol after exposure to control conditions, heat (42°C for 18 hours), okadaic acid (1 μg per milliliter for 1 hour), or hydrogen peroxide (0, 20, or 50 mmol per liter for 1 hour) before fixation (total culture time, 54 hours). The keratins were stained first with M20 and then with Texas Red–conjugated goat antimouse antibodies.16 Images were obtained with a confocal scanner (MRC 1024, Bio-Rad, Hercules, Calif.) with a microscope (Eclipse TE300, Nikon, Melville, N.Y.). The transfected cells were counted and categorized, according to the type of keratin filament they contained, as having normal filaments, collapsed filaments (visible as perinuclear collapse or thick bundles), or disassembled filaments (visible as dots or short filaments).
Statistical Analysis
Fisher's exact test (two-tailed)23 was used to analyze the proportion of patients with keratin 8 mutations in the group with cryptogenic liver disease in comparison with the proportion of those with keratin 8 mutations in the group with noncryptogenic disease and in comparison with the proportion of those with keratin 8 mutations in the group of randomly selected patients (the control group). Pearson's chi-square test23 was used to compare the filament phenotypes of transfected cells; 194 to 225 cells per construct were counted in two independent experiments.
Results
Identification of Mutations in the Keratin 8 Gene
We examined DNA extracted from specimens of explanted livers or peripheral blood for the presence of mutations in the keratin 8 or keratin 18 gene. Initially, DNA from two groups of patients — 55 with cryptogenic liver disease and 98 with noncryptogenic chronic or acute liver disease — was analyzed (Table 1Table 1
Racial or Ethnic Background and Sex of the Patients.). Isolated genomic DNA was used as a template to amplify exonic regions (a diagram is available as Supplementary Appendix 2
Supplementary Appendix 2. Structural Domains of Keratin 8 and Keratin 18, Regions That Were Analyzed for Mutations, and Comparison of the Amino Acid Sequences of Subdomain H1 of the Type II Keratins. with the full text of this article at http://www.nejm.org). Subsequent analysis of the amplified regions revealed the presence of a heterozygous mutation in three patients, consisting of a nucleotide change (G to T at codon 62), resulting in the replacement of glycine with cysteine at amino acid position 61 (G61C). Another heterozygous mutation was found in the DNA of two other patients (a change in nucleotide from T to C at codon 54), resulting in the replacement of tyrosine with histidine at position 53 (Y53H) (Figure 1AFigure 1Identification of Mutations in the Keratin 8 Gene and Expression of Mutant Keratin 8.). The G61C mutation predicted a new restriction site for the enzyme EcoT22I, and Y53H predicted a new restriction site for NcoI, predictions that were confirmed in additional experiments (data not shown). None of the 86 control patients without liver disease had either mutation, according to this analysis (data not shown). The mutations in the keratin 8 gene were found in 3 of 34 white patients and in 5 of 55 patients with cryptogenic cirrhosis, a significantly higher frequency than in the other groups of patients, who had no detectable mutations (Table 1).There were no significant associations between sex and the presence of mutations in the keratin 8 gene, and there were no specific histologic features associated with these mutations in the explanted-liver specimens (or pretransplantation liver-biopsy specimens that were available) that contained them. Two of the patients with the G61C mutation had autoimmune features. One patient with a history of multiple-substance abuse had mixed lymphocytic and plasma-cell infiltrates in her liver-biopsy specimen and explanted tissue, although serologic tests for autoimmunity were negative and she had no response to therapy with prednisone and azathioprine. One patient had elevated antinuclear antibodies (titer, 1:640) and anti–smooth-muscle antibodies (titer, 1:20), but her biopsy specimens did not contain plasma cells. One patient with the Y53H mutation had Mallory bodies but no history of alcohol abuse. None of the patients with a mutation in the keratin 8 gene had a history of diabetes or hyperlipidemia.
Expression of Mutant Keratin 8 Protein
We analyzed precipitates of keratin 8 and keratin 18 (Figure 1B) that were obtained from specimens of two normal livers and of three explanted livers with the G61C mutation by immunoblotting for keratin 8 under reducing and nonreducing conditions (Figure 1C). This approach takes advantage of the absence of cysteine residues in keratin 8 and keratin 18, which potentially could covalently link proteins that would otherwise not be linked. The three specimens with the G61C mutation but not the normal specimens (or specimens of cirrhotic livers [data not shown]) had a keratin 8 cross-linked species of approximately 100 kd that appeared only under nonreducing conditions (Figure 1C). The 100-kd species most likely corresponded to two keratin 8 molecules (covalently linked by two mutant cysteine residues), a finding that would be compatible with the normal tetrameric, noncovalent association of keratins (two keratin 8 molecules and two keratin 18 molecules) as heteropolymers24 and with lack of reactivity of the 100-kd species with keratin 18–specific antibodies (data not shown). Although an association between keratin 8 with the G61C mutation and other molecules cannot be excluded, our findings indicate that the G61C mutant protein was expressed in these three liver specimens.
The presence of the mutant Y53H protein was confirmed by assessing the change from the acidic tyrosine (isoelectric point, 5.63) to the basic histidine (isoelectric point, 7.64) on two-dimensional gel electrophoresis. Keratin 8 in normal liver consists of two charged isoforms: one that is unphosphorylated and one that is phosphorylated.18,21 In contrast, keratin 8 isolated from the explanted liver of a patient heterozygous for the Y53H mutation resolved into four isoforms — the two normal isoforms and two mutant Y53H isoforms (Figure 1D). As predicted, the mutant unphosphorylated isoform was more basic than the normal unphosphorylated isoform, because of the presence of the additional histidine. Assignment of the normal and mutant isoforms was confirmed by analysis of a mixture of normal and mutant samples (Figure 1D).
Mutations in the Keratin 8 Gene and Cell Stress
Given the well-established cytoprotective role of hepatocyte keratins,4,9 we compared the effect of cell stress on the reorganization of keratin filaments in normal keratin 8 and the mutant keratin 8. We examined stresses that induce reorganization of keratin filaments, including heat,25 the phosphatase inhibitor okadaic acid,26-28 and hydrogen peroxide.29 The protein with the Y53H mutation was associated with a significantly greater proportion of cells with unstable (collapsed or disassembled) filaments than was wild-type or G61C keratin 8 when cells were exposed to heat stress (20 percent, 56 percent, and 28 percent of cells transfected with wild-type, Y53H, and G61C keratin 8 DNA, respectively) or to okadaic acid (31 percent, 69 percent, and 31 percent, respectively) (P<0.001 for the comparison between the wild type or G61C and Y53H) (Figure 2Figure 2
Immunofluorescence Staining of NIH 3T3 Cells Transfected with Wild-Type and Mutant Keratin 8 Constructs.). In contrast, exposure to hydrogen peroxide prompted reorganization (visible as fine dots, a marker of unstable filaments) in 82 percent and 76 percent of cells transfected with wild-type and Y53H keratin 8 DNA, respectively, whereas only 35 percent of cells transfected with G61C keratin 8 DNA had a dot pattern (P<0.001 for the comparison between wild-type and G61C keratin 8) (Figure 2). The G61C and Y53H mutations had no effect on filament organization under basal conditions in cells transfected with these mutant proteins (data not shown).Discussion
The etiologic role of mutations in keratins and other intermediate-filament proteins, including desmin30-32 and lamins,33-36 in human disease is well established. Our findings add keratin 8 to the other “soft” keratins in which mutations have been associated with skin, oral, and ocular diseases.8 Additional mutations in the gene for keratin 8 and possibly keratin 18 may be found in association with liver disease. The five patients in whom we identified mutations in the keratin 8 gene and the patient in whom we identified a mutation in the keratin 18 gene18 all had cryptogenic cirrhosis, although two of these patients had some autoimmune features. Analysis of other patients with autoimmune disease should help clarify the role of mutations in the genes for keratin 8 and keratin 18 in autoimmune hepatitis. In addition, a greater number of patients without liver disease should be examined to estimate the prevalence of these mutations in the general population.
Two features of the glycine at position 61 of keratin 8 suggest that it is an important residue: it is located at a juncture between a predicted turn and a beta strand within the H1 head subdomain37 (as shown in Supplementary Appendix 2 at http://www.nejm.org), and it is conserved in all type II keratins. The H1 subdomain of the type II keratins is probably important in filament organization,38 and several mutations within H1 (none involving the conserved glycine at position 61) in the keratin 5 gene39,40 and the keratin 1 gene37,41,42 have been identified as the cause of epidermolysis bullosa simplex and epidermolytic hyperkeratosis, respectively.
Most of the epidermal, oral, and ocular keratin diseases are well-defined autosomal dominant diseases with a high penetrance. In contrast, and aside from rare reports of familial cirrhosis (which tends to be recessive),43 cryptogenic cirrhosis had been thought to be sporadic and of late onset. Thus, environmental or other genetic modifiers may contribute significantly to the expression of the disease. Notably, cryptogenic liver disease accounts for nearly 10 percent of all cases of liver disease.44,45 Although some conditions — including diabetes, obesity, nonalcoholic steatohepatitis, and surreptitious viral hepatitis — have been linked to cryptogenic liver disease,45-48 it remains poorly understood. Studies in animals11-17 support the hypothesis that mutations in the keratin 8 and keratin 18 genes may place carriers at high risk for liver disease rather than directly cause liver disease. The mutations we describe are likely to be pathogenic factors and not polymorphisms, since they were found in the group of patients with cryptogenic cirrhosis but not in the group with noncryptogenic liver disease or the control group and since they resulted in phenotypes of resistance to filament reorganization (in the case of the G61C mutation) and filament instability (in the case of the Y53H mutation) in transfected cells exposed to stress. These findings agree well with the known cytoprotective function of keratin 8 and keratin 18 in the liver.4,9-17
In the epidermal keratins, genetic and environmental modifiers may result in different diseases for a given mutation at a given site of the keratin. For example, a specific mutation of the keratin 17 gene (the substitution of cysteine for arginine at position 94) was associated with steatocystoma multiplex in one family but pachyonychia congenita type 2 in another.49 If mouse phenotypes can be extrapolated to humans, as is true of several animal models of keratin disease,3,9,10 then it is possible that diseases that do not primarily involve the liver may also be associated with mutations in the keratin 8 gene. This hypothesis is supported by the finding that different inbred strains of mice that lack the keratin 8 gene have markedly different phenotypes, primarily intestinal disease or liver disease, depending on the particular strain.11,12
The physiological consequences of the Y53H and G61C mutations in the keratin 8 gene are probably related to the dynamic nature and reorganization that keratins undergo during cellular events, including mitosis and stress.2-4 These mutations do not affect the organization of keratin filaments under basal conditions, but they do result in substantial abnormal reorganization of the filaments in transfected cells exposed to stress. The stresses we tested included heat, oxidative stress (hydrogen peroxide), and exposure to okadaic acid, all of which induce the hyperphosphorylation and reorganization of keratins in normal cells.4 The hepatotoxin and phosphatase inhibitor microcystin, which causes marked hyperphosphorylation and reorganization of keratin,14,26-28 accounted for several deaths due to liver failure.50 One of our two patients with a G61C mutation in the keratin 8 gene had been repeatedly exposed to halothane, and another had used cocaine regularly and alcohol occasionally. Halothane is a known hepatic toxin,51 and mice lacking the keratin 8 gene are highly susceptible to anesthetics with hepatotoxic properties13; alcohol and cocaine synergistically promote oxidative stress in hepatocytes.52 We propose that mutations in the keratin 8 gene or the keratin 18 gene predispose patients to liver disease at least in part by interfering with the normal reorganization of keratin filaments (and its presumed functional sequelae) that occurs in response to physiological and nonphysiological stimuli. Further studies should clarify the role of genetic and environmental modifiers in such liver disease and the potential presence of these mutations in other diseases.
Supported by Veterans Affairs Merit and Career Development awards and by a grant from the National Institutes of Health (DK52951), to Dr. Omary.
We are indebted to Dr. Roy Soetikno for performing the statistical analysis; to Dr. Robert Garcia-Kennedy (California Pacific Medical Center) for assistance with the histologic analyses; to Linda Brooks, Peggy Newsom, and Tigist Belaye for assistance with the liver samples and clinical information; to Kris Morrow for preparation of the figures; to Linda Jacob and Blanca Pineda for assistance in the preparation of the manuscript; to Li Feng for laboratory assistance; and to the patients who made their explanted tissue and blood samples available to allow us to carry out this study.
Source Information
From the Gastroenterology Section, Palo Alto Veterans Affairs Medical Center and Stanford University School of Medicine, Palo Alto, Calif. (N.-O.K., M.B.O.); the Department of Transplantation, California Pacific Medical Center, San Francisco (R.G.); and the Gastroenterology Section, San Francisco Veterans Affairs Medical Center, San Francisco (T.L.W.).
Address reprint requests to Dr. Ku at the Palo Alto Veterans Affairs Medical Center, Mail Code 154J, 3801 Miranda Ave., Palo Alto, CA 94304.
- References
References
1
Moll R ,Frank WW ,Schiller DL ,Geiger B ,Kreple R . The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24
CrossRef | Web of Science | Medline2
Fuchs E ,Weber K . Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994;63:345-382
CrossRef | Web of Science | Medline3
Fuchs E ,Cleveland DW . A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-519
CrossRef | Web of Science | Medline4
Ku N-O ,Zhou X ,Toivola DM ,Omary MB . The cytoskeleton of digestive epithelia in health and disease. Am J Physiol 1999;277:G1108-G1137
Web of Science | Medline5
Fuchs E ,Coulombe PA . Of mice and men: genetic skin diseases of keratin. Cell 1992;69:899-902
CrossRef | Web of Science | Medline6
Steinert PM ,Bale SJ . Genetic skin diseases caused by mutations in keratin intermediate filaments. Trends Genet 1993;9:280-284
CrossRef | Web of Science | Medline7
McLean WHI ,Lane EB . Intermediate filaments in disease. Curr Opin Cell Biol 1995;7:118-125
CrossRef | Web of Science | Medline8
Irvine AD ,McLean WHI . Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999;140:815-828
CrossRef | Web of Science | Medline9
Omary MB ,Ku N-O . Intermediate filament proteins of the liver: emerging disease association and functions. Hepatology 1997;25:1043-1048
CrossRef | Web of Science | Medline10
Magin TM . Lessons from keratin transgenic and knockout mice. Subcell Biochem 1998;31:141-172
Medline11
Baribault H ,Price J ,Miyai K ,Oshima RG . Mid-gestational lethality in mice lacking keratin 8. Genes Dev 1993;7:1191-1202
CrossRef | Web of Science | Medline12
Baribault H ,Penner J ,Iozzo RV ,Wilson-Heiner M . Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8:2964-2973
CrossRef | Web of Science | Medline13
Loranger A ,Duclos S ,Grenier A , et al. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol 1997;151:1673-1683
Web of Science | Medline14
Toivola DM ,Omary MB ,Ku N-O ,Peltola O ,Baribault H ,Eriksson JE . Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity. Hepatology 1998;28:116-128
CrossRef | Web of Science | Medline15
Zatloukal K ,Stumptner C ,Lehner M , et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000;156:1263-1274
CrossRef | Web of Science | Medline16
Ku N-O ,Michie S ,Oshima RG ,Omary MB . Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 1995;131:1303-1314
CrossRef | Web of Science | Medline17
Ku N-O ,Michie SA ,Soetikno RM , et al. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 1996;98:1034-1046
CrossRef | Web of Science | Medline18
Ku N-O ,Wright TL ,Terrault NA ,Gish R ,Omary MB . Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest 1997;99:19-23
CrossRef | Web of Science | Medline19
Kulesh DA ,Cecena G ,Darmon YM ,Vasseur M ,Oshima RG . Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol 1989;9:1553-1565
Web of Science | Medline20
Ku N-O ,Omary MB . Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J Cell Biol 2000;149:547-552
CrossRef | Web of Science | Medline21
Liao J ,Ku N-O ,Omary MB . Two-dimensional gel analysis of glandular keratin intermediate filament phosphorylation. Electrophoresis 1996;17:1671-1676
CrossRef | Web of Science | Medline22
Laemmli UK . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685
CrossRef | Web of Science | Medline23
JMP statistics and graphics guide, version 3.1. Cary, N.C.: SAS Institute, 1995.
24
Quinlan RA ,Cohlberg JA ,Schiller DL ,Hatzfeld M ,Franke WW . Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells. J Mol Biol 1984;178:365-388
CrossRef | Web of Science | Medline25
Liao J ,Lowthert LA ,Omary MB . Heat stress or rotavirus infection of human epithelial cells generates a distinct hyperphosphorylated form of keratin 8. Exp Cell Res 1995;219:348-357
CrossRef | Web of Science | Medline26
Ohta T ,Nishiwaki R ,Yatsunami A ,Komori A ,Suganuma M ,Fujiki M . Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes. Carcinogenesis 1992;13:2443-2447
CrossRef | Web of Science | Medline27
Toivola DM ,Goldman RD ,Garrod DR ,Eriksson JE . Protein phosphatases maintain the organization and structural interactions of hepatic keratin intermediate filaments. J Cell Sci 1997;110:23-33
Web of Science | Medline28
Ku NO ,Michie SA ,Soetikno RM ,Resurreccion EZ ,Broome RL ,Omary MB . Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J Cell Biol 1998;143:2023-2032
CrossRef | Web of Science | Medline29
Raghu G ,Striker L ,Harlan J ,Gown A ,Striker G . Cytoskeletal changes as an early event in hydrogen peroxide-induced cell injury: a study in A549 cells. Br J Exp Pathol 1986;67:105-112
Web of Science | Medline30
Munoz-Marmol AM ,Strasser G ,Isamat M , et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci U S A 1998;95:11312-11317
CrossRef | Web of Science | Medline31
Goldfarb LG ,Park KY ,Cervenakova L , et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402-403
CrossRef | Web of Science | Medline32
Dalakas MC ,Park K-Y ,Semino-Mora C ,Lee HS ,Sivakumar K ,Goldfarb LG . Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000;342:770-780
Full Text | Web of Science | Medline33
Bonne G ,Di Barletta MR ,Varnous S , et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999;21:285-288
CrossRef | Web of Science | Medline34
Fatkin D ,MacRae C ,Sasaki T , et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1715-1724
Full Text | Web of Science | Medline35
Shackleton S ,Lloyd DJ ,Jackson SNJ , et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000;24:153-156
CrossRef | Web of Science | Medline36
Cao H ,Hegele RA . Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000;9:109-112
CrossRef | Web of Science | Medline37
Chipev CC ,Korge BP ,Markova N , et al. A leucine →proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992;70:821-828
CrossRef | Web of Science | Medline38
Steinert PM ,Parry DAD . The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two- to four-molecule level of structure. J Biol Chem 1993;268:2878-2887
Web of Science | Medline39
Chan YM ,Yu QC ,Fine JD ,Fuchs E . The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc Natl Acad Sci U S A 1993;90:7414-7418
CrossRef | Web of Science | Medline40
Muller FB ,Kuster W ,Bruckner-Tuderman L ,Korge BP . Novel K5 and K14 mutations in German patients with the Weber-Cockayne variant epidermolysis bullosa simplex. J Invest Dermatol 1998;111:900-902
CrossRef | Web of Science | Medline41
Yang J-M ,Chipev CC ,DiGiovanna JJ , et al. Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. J Invest Dermatol 1994;102:17-23
CrossRef | Web of Science | Medline42
Yang J-M ,Nam K ,Park KB , et al. A novel H1 mutation in the keratin 1 chain in epidermolytic hyperkeratosis. J Invest Dermatol 1996;107:439-441
CrossRef | Web of Science | Medline43
Muller T ,Schafer H ,Rodeck B , et al. Familial clustering of infantile cirrhosis in northern Germany: a clue to the etiology of idiopathic copper toxicosis. J Pediatr 1999;135:189-196
CrossRef | Web of Science | Medline44
Charlton MR ,Kondo M ,Roberts SK ,Steers JL ,Krom RAF ,Wiesner RH . Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg 1997;3:359-364
CrossRef | Medline45
Kingham JGC . Dissecting out cryptogenic liver disease. Gut 2000;47:328-329
CrossRef | Web of Science | Medline46
Caldwell SH ,Oelsner DH ,Iezzoni JC ,Hespenheide EE ,Battle EH ,Driscoll CJ . Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669
CrossRef | Web of Science | Medline47
Poonawala A ,Nair SP ,Thuluvath PJ . Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-692
CrossRef | Web of Science | Medline48
Struben VM ,Hespenheide EE ,Caldwell SH . Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000;108:9-13
CrossRef | Web of Science | Medline49
Covello SP ,Smith FJ ,Sillevis Smitt JH , et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998;139:475-480
CrossRef | Web of Science | Medline50
Jochimsen EM ,Carmichael WW ,An J , et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med 1998;338:873-878[Erratum, N Engl J Med 1998;339:139.]
Full Text | Web of Science | Medline51
Hoet P ,Graf ML ,Bourdi M , et al. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutions of chlorofluorocarbons. Lancet 1997;350:556-559
CrossRef | Web of Science | Medline52
Ponsoda X ,Bort R ,Jover R ,Gomez-Lechon MJ ,Castell JV . Increased toxicity of cocaine on human hepatocytes induced by ethanol: role of GSH. Biochem Pharmacol 1999;58:1579-1585
CrossRef | Web of Science | Medline
- Citing Articles (60)
Citing Articles
1
Albert J. Czaja. (2011) Autoantibody-Negative Autoimmune Hepatitis. Digestive Diseases and Sciences
CrossRef2
Pierre-Yves Delavalle, Khaled Alsaleh, André Pillez, Laurence Cocquerel, Cécile Allet, Patrick Dumont, Anne Loyens, Emmanuelle Leteurtre, M. Bishr Omary, Jean Dubuisson, Yves Rouillé, Czeslaw Wychowski. (2011) Hepatocyte-derived cultured cells with unusual cytoplasmic keratin-rich spheroid bodies. Experimental Cell Research 317:18, 2683-2694
CrossRef3
Mina O. Rakoski, Morton B. Brown, Robert J. Fontana, Herbert L. Bonkovsky, Elizabeth M. Brunt, Zachary D. Goodman, Anna S. Lok, M. Bishr Omary. (2011) Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 9:10, 902-909.e1
CrossRef4
Albert J. Czaja. (2011) Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Digestive Diseases and Sciences
CrossRef5
Maurice A. M. van Steensel, Peter M. Steijlen. 2011. Review of Keratin Disorders. , 117.1-117.9.
CrossRef6
Daniel Hartmann, Ujala Srivastava, Michaela Thaler, Karin N. Kleinhans, Gisèle N'Kontchou, Annika Scheffold, Kerstin Bauer, Ramona F. Kratzer, Natalia Kloos, Sarah-Fee Katz, Zhangfa Song, Yvonne Begus-Nahrmann, Alexander Kleger, Guido von Figura, Pavel Strnad, André Lechel, Cagatay Günes, Andrej Potthoff, Katja Deterding, Heiner Wedemeyer, Zhenyu Ju, Ge Song, Feng Xiao, Sonja Gillen, Hubert Schrezenmeier, Thomas Mertens, Marianne Ziol, Helmut Friess, Michael Jarek, Michael P. Manns, Michel Beaugrand, K. Lenhard Rudolph. (2011) Telomerase gene mutations are associated with cirrhosis formation. Hepatology 53:5, 1608-1617
CrossRef7
A. Habtezion, D. M. Toivola, M. N. Asghar, G. S. Kronmal, J. D. Brooks, E. C. Butcher, M. B. Omary. (2011) Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proceedings of the National Academy of Sciences 108:4, 1445-1450
CrossRef8
V Karantza. (2011) Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30:2, 127-138
CrossRef9
Anne-Marie Fortier, Kathleen Riopel, Martin Désaulniers, Monique Cadrin. (2010) Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury. Experimental and Molecular Pathology 89:2, 117-125
CrossRef10
Pavel Strnad, Qin Zhou, Shinichiro Hanada, Laura C. Lazzeroni, Bi Hui Zhong, Phillip So, Timothy J. Davern, William M. Lee, M. Bishr Omary. (2010) Keratin Variants Predispose to Acute Liver Failure and Adverse Outcome: Race and Ethnic Associations. Gastroenterology 139:3, 828-835.e3
CrossRef11
Nam-On Ku, Diana M. Toivola, Pavel Strnad, M. Bishr Omary. (2010) Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nature Cell Biology 12:9, 876-885
CrossRef12
Stephen Caldwell. (2010) Cryptogenic Cirrhosis: What Are We Missing?. Current Gastroenterology Reports 12:1, 40-48
CrossRef13
Bihui Zhong, Pavel Strnad, Carlo Selmi, Pietro Invernizzi, Guo-Zhong Tao, Angela Caleffi, Minhu Chen, Ilaria Bianchi, Mauro Podda, Antonello Pietrangelo, M. Eric Gershwin, M. Bishr Omary. (2009) Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 50:2, 546-554
CrossRef14
M. Bishr Omary, Nam-On Ku, Pavel Strnad, Shinichiro Hanada. (2009) Toward unraveling the complexity of simple epithelial keratins in human disease. Journal of Clinical Investigation 119:7, 1794-1805
CrossRef15
Anna Kakehashi, Masayo Inoue, Min Wei, Shoji Fukushima, Hideki Wanibuchi. (2009) Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas. Toxicology and Applied Pharmacology 238:1, 71-79
CrossRef16
M. Bishr Omary. (2009) “IF-pathies”: a broad spectrum of intermediate filament–associated diseases. Journal of Clinical Investigation 119:7, 1756-1762
CrossRef17
L. Leifeld, S. Kothe, G. Söhl, M. Hesse, T. Sauerbruch, T. M. Magin, U. Spengler. (2009) Keratin 18 provides resistance to Fas-mediated liver failure in mice. European Journal of Clinical Investigation 39:6, 481-488
CrossRef18
C. W. M. Chan, N. A. Wong, Y. Liu, D. Bicknell, H. Turley, L. Hollins, C. J. Miller, J. L. Wilding, W. F. Bodmer. (2009) Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proceedings of the National Academy of Sciences 106:6, 1936-1941
CrossRef19
P. Strnad, C. Stumptner, K. Zatloukal, H. Denk. (2008) Intermediate filament cytoskeleton of the liver in health and disease. Histochemistry and Cell Biology 129:6, 735-749
CrossRef20
Pavel Strnad, Guo–Zhong Tao, Qin Zhou, Masaru Harada, Diana M. Toivola, Elizabeth M. Brunt, M. Bishr Omary. (2008) Keratin Mutation Predisposes to Mouse Liver Fibrosis and Unmasks Differential Effects of the Carbon Tetrachloride and Thioacetamide Models. Gastroenterology 134:4, 1169-1179
CrossRef21
Hiroto Kumemura, Masaru Harada, Chikatoshi Yanagimoto, Hironori Koga, Takumi Kawaguchi, Shinichiro Hanada, Eitaro Taniguchi, Takato Ueno, Michio Sata. (2008) Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cells. Biochemical and Biophysical Research Communications 367:1, 33-40
CrossRef22
Nam-On Ku, Pavel Strnad, Bi-Hui Zhong, Guo-Zhong Tao, M. Bishr Omary. (2007) Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology 46:5, 1639-1649
CrossRef23
Guo–Zhong Tao, Pavel Strnad, Qin Zhou, Ahmad Kamal, Leilei Zhang, Nahid D. Madani, Subra Kugathasan, Steven R. Brant, Judy H. Cho, M. Bishr Omary, Richard H. Duerr. (2007) Analysis of Keratin Polypeptides 8 and 19 Variants in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 5:7, 857-864
CrossRef24
A. Aigelsreiter, E. Janig, C. Stumptner, A. Fuchsbichler, K. Zatloukal, H. Denk. (2007) How a Cell Deals with Abnormal Proteins. Pathobiology 74:3, 145-158
CrossRef25
Masaru Harada, Pavel Strnad, Evelyn Z. Resurreccion, Nam-On Ku, M. Bishr Omary. (2007) Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology 45:1, 88-96
CrossRef26
Matthias Treiber, Hans-Ulrich Schulz, Olfert Landt, Joost PH Drenth, Carlo Castellani, Francisco X. Real, Nejat Akar, Rudolf W. Ammann, Mario Bargetzi, Eesh Bhatia, Andrew Glenn Demaine, Cinzia Battagia, Andrew Kingsnorth, Derek O’Reilly, Kaspar Truninger, Monika Koudova, Julius Spicak, Milos Cerny, Hans-Jürgen Menzel, Pedro Moral, Pier Franco Pignatti, Maria Grazia Romanelli, Olga Rickards, Gian Franco De Stefano, Narcis Octavian Zarnescu, Gourdas Choudhuri, Sadiq S. Sikora, Jan B. M. J. Jansen, Frank Ulrich Weiss, Matthias Pietschmann, Niels Teich, Thomas M. Gress, Johann Ockenga, Hartmut Schmidt, Andreas Kage, Juliane Halangk, Jonas Rosendahl, David Alexander Groneberg, Renate Nickel, Heiko Witt. (2006) Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. Journal of Molecular Medicine 84:12, 1015-1022
CrossRef27
Maximilian Schoniger-Hekele, Dagmar Petermann, Christian Muller. (2006) Mutation of keratin 8 in patients with liver disease. Journal of Gastroenterology and Hepatology 0:0, 060613040113017-???
CrossRef28
Pavel Strnad, Tim C. Lienau, Guo-Zhong Tao, Laura C. Lazzeroni, Felix Stickel, Detlef Schuppan, M. Bishr Omary. (2006) Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology 43:6, 1354-1363
CrossRef29
Pavel Strnad, Tim Christian Lienau, Guo-Zhong Tao, Nam-On Ku, Thomas M. Magin, M. Bishr Omary. (2006) Denaturing temperature selection may underestimate keratin mutation detection by DHPLC. Human Mutation 27:5, 444-452
CrossRef30
Alexander Schneider, Janette Lamb, M. Michael Barmada, Anthony Cuneo, Mary E. Money, David C. Whitcomb. (2006) Keratin 8 Mutations Are Not Associated with Familial, Sporadic and Alcoholic Pancreatitis in a Population from the United States. Pancreatology 6:1-2, 103-108
CrossRef31
Nam–On Ku, Joseph K. Lim, Sheri M. Krams, Carlos O. Esquivel, Emmet B. Keeffe, Teresa L. Wright, David A.D. Parry, M. Bishr Omary. (2005) Keratins as Susceptibility Genes for End-Stage Liver Disease. Gastroenterology 129:3, 885-893
CrossRef32
Ayano Inui, Tsuyoshi Sogo, Haruki Komatsu, Hiroshi Miyakawa, Tomoo Fujisawa. (2005) Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation. Liver Transplantation 11:5, 504-507
CrossRef33
Takuji Nabetani, Yo Tabuse, Akira Tsugita, Junichi Shoda. (2005) Proteomic analysis of livers of patients with primary hepatolithiasis. PROTEOMICS 5:4, 1043-1061
CrossRef34
Qin Zhou, Xuhuai Ji, Lixin Chen, Harry B. Greenberg, Shelly C. Lu, M. Bishr Omary. (2005) Keratin mutation primes mouse liver to oxidative injury. Hepatology 41:3, 517-525
CrossRef35
H DENK, C STUMPTNER, A FUCHSBICHLER, K ZATLOUKAL. (2004) Mallory bodies and liver diseases. Journal of Gastroenterology and Hepatology 19:s7, S349-S352
CrossRef36
Eli Sprecher. 2004. Keratin Disorders. , 693-699.
CrossRef37
Elizabeth L. Rugg, Irene M. Leigh. (2004) The keratins and their disorders. American Journal of Medical Genetics 131C:1, 4-11
CrossRef38
Kurt Zatloukal, Conny Stumptner, Andrea Fuchsbichler, Peter Fickert, Carolin Lackner, Michael Trauner, Helmut Denk. (2004) The keratin cytoskeleton in liver diseases. The Journal of Pathology 204:4, 367-376
CrossRef39
DW Owens, EB Lane. (2004) Keratin mutations and intestinal pathology. The Journal of Pathology 204:4, 377-385
CrossRef40
Pierre A. Coulombe, Pauline Wong. (2004) Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nature Cell Biology 6:8, 699-706
CrossRef41
Diana M. Toivola, Nam-On Ku, Evelyn Z. Resurreccion, David R. Nelson, Teresa L. Wright, M. Bishr Omary. (2004) Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 40:2, 459-466
CrossRef42
D.J. de Jong, J.P.H. Drenth. (2004) Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study. Digestive and Liver Disease 36:6, 380-383
CrossRef43
C. Büning, J. Halangk, A. Dignass, J. Ockenga, P. Deindl, R. Nickel, J. Genschel, O. Landt, H. Lochs, H. Schmidt, H. Witt. (2004) Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Digestive and Liver Disease 36:6, 388-391
CrossRef44
George K Anagnostopoulos, George Margantinis, Stavros Tsiakos, Panagiotis Kostopoulos, Dimitrios Arvanitidis. (2004) Liver cirrhosis observed in a patient with chronic excessive menthol intake. Journal of Gastroenterology and Hepatology 19:2, 239-240
CrossRef45
Jeffrey D. Browning, K. Shiva Kumar, M. Hossein Saboorian, Dwain L. Thiele. (2004) Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis. The American Journal of Gastroenterology 99:2, 292-298
CrossRef46
Hiroto Kumemura, Masaru Harada, M. Bishr Omary, Shotaro Sakisaka, Tatsuo Suganuma, Masayoshi Namba, Michio Sata. (2004) Aggregation and loss of cytokeratin filament networks inhibit Golgi organization in liver-derived epithelial cell lines. Cell Motility and the Cytoskeleton 57:1, 37-52
CrossRef47
TAE-HYUNG KIM, BYUNG-HO KIM, YOUN-WHA KIM, DAL MO YANG, YO-SEB HAN, SEOK HO DONG, HYO JONG KIM, YOUNG-WOON CHANG, JOUNG IL LEE, RIN CHANG. (2003) Liver cirrhosis developed after ketoconazole-induced acute hepatic injury. Journal of Gastroenterology and Hepatology 18:12, 1426-1429
CrossRef48
Dewi W. Owens, E. Birgitte Lane. (2003) The quest for the function of simple epithelial keratins. BioEssays 25:8, 748-758
CrossRef49
J.P.H Drenth, M Verlaan. (2003) Genetic aspects of chronic pancreatitis, and the exploration of an association with keratin 8/18. Digestive and Liver Disease 35:6, 386-388
CrossRef50
G.M Cavestro, L Frulloni, A Nouvenne, T.M Neri, B Calore, B Ferri, P Bovo, L Okolicsanyi, F Di Mario, G Cavallini. (2003) Association of keratin 8 gene mutation with chronic pancreatitis. Digestive and Liver Disease 35:6, 416-420
CrossRef51
Rebecca M. Porter, E. Birgitte Lane. (2003) Phenotypes, genotypes and their contribution to understanding keratin function. Trends in Genetics 19:5, 278-285
CrossRef52
Frances J D Smith. (2003) The Molecular Genetics of Keratin Disorders. American Journal of Clinical Dermatology 4:5, 347-364
CrossRef53
Pauline Lee, Terri Gelbart, Carol West, Carol Halloran, Ernest Beutler. (2002) Seeking Candidate Mutations That Affect Iron Homeostasis. Blood Cells, Molecules, and Diseases 29:3, 471-487
CrossRef54
Frances J.D Smith, Rebecca M Porter, Laura D Corden, Declan P Lunny, E Birgitte Lane, W.H Irwin McLean. (2002) Cloning of human, murine, and marsupial keratin 7 and a survey of K7 expression in the mouse. Biochemical and Biophysical Research Communications 297:4, 818-827
CrossRef55
Jay H. Lefkowitch. (2002) Hepatobiliary pathology. Current Opinion in Gastroenterology 18:3, 290-298
CrossRef56
Neil V. Whittock, Frances J. Smith, Hong Wan, Rajeev Mallipeddi, W. Andrew Griffiths, Patricia Dopping-Hepenstal, Gabrielle H. Ashton, Robin A. Eady, W. H. Irwin McLean, John A. McGrath. (2002) Frameshift Mutation in the V2 Domain of Human Keratin 1 Results in Striate Palmoplantar Keratoderma. Journal of Investigative Dermatology 118:5, 838-844
CrossRef57
P G Chu, L M Weiss. (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:5, 403-439
CrossRef58
Pierre A Coulombe, M.Bishr Omary. (2002) ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments. Current Opinion in Cell Biology 14:1, 110-122
CrossRef59
Peter Fickert, Michael Trauner, Andrea Fuchsbichler, Conny Stumptner, Kurt Zatloukal, Helmut Denk. (2002) Cytokeratins as Targets for Bile Acid-Induced Toxicity. The American Journal of Pathology 160:2, 491-499
CrossRef60
Normand Marceau, Anne Loranger, Stéphane Gilbert, Nathalie Daigle, Serge Champetier. (2001) Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. Biochemistry and Cell Biology 79:5, 543-555
CrossRef
